| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 9 | 3 | |
| Lipodystrophy (lipoatrophy or loss of fatty tissue) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Weight gain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 2 |